HRTX
Heron Therapeutics Inc

7,349
Mkt Cap
$240.2M
Volume
1.71M
52W High
$2.68
52W Low
$0.9999
PE Ratio
-16.19
HRTX Fundamentals
Price
$1.31
Prev Close
$1.31
Open
$1.29
50D MA
$1.20
Beta
1.41
Avg. Volume
2.2M
EPS (Annual)
-$0.0891
P/B
34.19
Rev/Employee
$1.18M
Loading...
Loading...
News
all
press releases
Heron Therapeutics, Inc. (NASDAQ:HRTX) Given Consensus Recommendation of "Hold" by Analysts
Shares of Heron Therapeutics, Inc. (NASDAQ:HRTX - Get Free Report) have earned a consensus recommendation of "Hold" from the five research firms that are presently covering the stock, Marketbeat...
MarketBeat·7d ago
News Placeholder
More News
News Placeholder
Heron Therapeutics, Inc. $HRTX Shares Sold by Orchard Capital Management LLC
Orchard Capital Management LLC lowered its stake in shares of Heron Therapeutics, Inc. (NASDAQ:HRTX - Free Report) by 53.9% in the second quarter, according to its most recent Form 13F filing with...
MarketBeat·8d ago
News Placeholder
Jefferies Financial Group Inc. Acquires 344,200 Shares of Heron Therapeutics, Inc. $HRTX
Jefferies Financial Group Inc. boosted its stake in shares of Heron Therapeutics, Inc. (NASDAQ:HRTX - Free Report) by 106.7% during the 2nd quarter, according to its most recent 13F filing with the...
MarketBeat·9d ago
News Placeholder
What is Northland Capmk's Estimate for HRTX FY2026 Earnings?
Heron Therapeutics, Inc. (NASDAQ:HRTX - Free Report) - Equities research analysts at Northland Capmk issued their FY2026 earnings estimates for Heron Therapeutics in a research report issued to...
MarketBeat·29d ago
News Placeholder
What is HC Wainwright's Forecast for HRTX FY2025 Earnings?
Heron Therapeutics, Inc. (NASDAQ:HRTX - Free Report) - Equities research analysts at HC Wainwright dropped their FY2025 earnings per share (EPS) estimates for Heron Therapeutics in a research note...
MarketBeat·1mo ago
News Placeholder
What is HC Wainwright's Forecast for HRTX FY2027 Earnings?
Heron Therapeutics, Inc. (NASDAQ:HRTX - Free Report) - Research analysts at HC Wainwright cut their FY2027 earnings per share (EPS) estimates for Heron Therapeutics in a report released on Tuesday...
MarketBeat·1mo ago
News Placeholder
Heron Therapeutics (HRTX) Q3 Earnings: How Key Metrics Compare to Wall Street Estimates
Although the revenue and EPS for Heron Therapeutics (HRTX) give a sense of how its business performed in the quarter ended September 2025, it might be worth considering how some key metrics compare with Wall Street estimates and the year-ago numbers.
Zacks·1mo ago
News Placeholder
Heron Therapeutics (HRTX) Reports Q3 Loss, Misses Revenue Estimates
Heron Therapeutics (HRTX) delivered earnings and revenue surprises of -150.00% and -0.91%, respectively, for the quarter ended September 2025. Do the numbers hold clues to what lies ahead for the stock?
Zacks·1mo ago
News Placeholder
Heron Therapeutics (HRTX) Q2 Earnings: Taking a Look at Key Metrics Versus Estimates
Although the revenue and EPS for Heron Therapeutics (HRTX) give a sense of how its business performed in the quarter ended June 2025, it might be worth considering how some key metrics compare with Wall Street estimates and the year-ago numbers.
Zacks·4mo ago
News Placeholder
Heron Therapeutics (HRTX) Reports Q2 Loss, Misses Revenue Estimates
Heron Therapeutics (HRTX) delivered earnings and revenue surprises of -100.00% and -1.89%, respectively, for the quarter ended June 2025. Do the numbers hold clues to what lies ahead for the stock?
Zacks·4mo ago

Latest HRTX News

View

Advertisement|Remove ads.

Advertisement|Remove ads.